Zacks Research Brokers Raise Earnings Estimates for STERIS

STERIS plc (NYSE:STE) – Zacks Research raised their Q1 2027 earnings per share (EPS) estimates for STERIS in a note issued to investors on Wednesday, August 27th. Zacks Research analyst Team now forecasts that the medical equipment provider will post earnings per share of $2.87 for the quarter, up from their prior forecast of $2.69. The consensus estimate for STERIS’s current full-year earnings is $9.08 per share. Zacks Research also issued estimates for STERIS’s Q4 2027 earnings at $3.07 EPS.

A number of other equities analysts have also weighed in on STE. KeyCorp upped their target price on shares of STERIS from $277.00 to $288.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 22nd. JMP Securities raised their price objective on STERIS from $265.00 to $280.00 and gave the company a “market outperform” rating in a research report on Friday, May 16th. Jefferies Financial Group began coverage on STERIS in a report on Thursday, May 29th. They issued a “hold” rating and a $263.00 target price on the stock. Citigroup reiterated an “outperform” rating on shares of STERIS in a research report on Friday, May 16th. Finally, Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 9th. Six investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, STERIS has an average rating of “Moderate Buy” and a consensus price target of $273.50.

STERIS Stock Down 1.3%

NYSE STE opened at $241.93 on Monday. STERIS has a 12 month low of $200.98 and a 12 month high of $252.79. The company has a current ratio of 2.22, a quick ratio of 1.53 and a debt-to-equity ratio of 0.27. The stock has a market cap of $23.83 billion, a PE ratio of 37.05 and a beta of 0.95. The stock’s 50 day moving average is $236.19 and its 200 day moving average is $231.76.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, August 6th. The medical equipment provider reported $2.34 earnings per share for the quarter, topping analysts’ consensus estimates of $2.32 by $0.02. The firm had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.36 billion. STERIS had a return on equity of 14.17% and a net margin of 11.61%.The business’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.03 earnings per share.

STERIS Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 26th. Stockholders of record on Thursday, September 4th will be issued a $0.63 dividend. This is a positive change from STERIS’s previous quarterly dividend of $0.57. The ex-dividend date is Thursday, September 4th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.0%. STERIS’s dividend payout ratio (DPR) is presently 34.92%.

Insider Activity

In related news, CAO Karen L. Burton sold 7,900 shares of the firm’s stock in a transaction on Monday, August 11th. The stock was sold at an average price of $241.73, for a total value of $1,909,667.00. Following the completion of the sale, the chief accounting officer directly owned 5,994 shares in the company, valued at $1,448,929.62. This trade represents a 56.86% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Renato Tamaro sold 3,204 shares of the business’s stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $249.24, for a total transaction of $798,564.96. Following the transaction, the vice president owned 7,221 shares in the company, valued at $1,799,762.04. This trade represents a 30.73% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 36,335 shares of company stock worth $8,822,302. Company insiders own 1.07% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. QRG Capital Management Inc. raised its holdings in shares of STERIS by 122.5% in the first quarter. QRG Capital Management Inc. now owns 2,832 shares of the medical equipment provider’s stock worth $642,000 after buying an additional 1,559 shares during the period. Allianz Asset Management GmbH grew its position in STERIS by 31.9% in the 1st quarter. Allianz Asset Management GmbH now owns 102,488 shares of the medical equipment provider’s stock valued at $23,229,000 after acquiring an additional 24,809 shares during the last quarter. Dynamic Advisor Solutions LLC increased its stake in STERIS by 23.6% in the first quarter. Dynamic Advisor Solutions LLC now owns 1,203 shares of the medical equipment provider’s stock worth $273,000 after purchasing an additional 230 shares during the period. Golden State Wealth Management LLC lifted its position in shares of STERIS by 503.0% during the first quarter. Golden State Wealth Management LLC now owns 199 shares of the medical equipment provider’s stock worth $45,000 after purchasing an additional 166 shares during the last quarter. Finally, Vontobel Holding Ltd. boosted its stake in shares of STERIS by 17.1% during the first quarter. Vontobel Holding Ltd. now owns 2,071 shares of the medical equipment provider’s stock valued at $469,000 after purchasing an additional 302 shares during the period. Hedge funds and other institutional investors own 94.69% of the company’s stock.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.